Cardiovascular and Endocrine Response to Muscular Training Program of Young Soccer Players Aged 14-18 Years

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age14-18
SponsorHôpital Fribourgeois

About this trial

This study focuses on understanding the cardiovascular and endocrine responses of young soccer players aged 14 to 18 years to a muscular training program. Adolescence is a critical period for physiological development, and investigating these responses can provide insights crucial for athletic performance and overall health. The benefits include promoting overall health, reducing injury risk, and enhancing scientific knowledge. However, intensive training programs may lead to overtraining and potential negative health outcomes if not carefully monitored. The study aims to assess whether additional neuromuscular development over 12 weeks can enhance players' physical fitness and hormonal changes. By examining these outcomes, the study seeks to inform evidence-based training protocols for optimizing adolescent athletes' health and performance in soccer. The study design involves a prospective single-center randomized cohort to investigate these responses comprehensively.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Engaging in a football training program.

No history of injuries in the last 6 months requiring surgical intervention.

No intake of anabolic supplements.

Age 14-18 years old.

Disqualifiers

Engaging in other supplemental individual exercise programs.

Being a smoker (>1 cigarette/week).

Using any medication at the time of testing.

Having any disease.

Trial design

Design model

Parallel

Treatments tested in this trial

  • neuromuscular programm

    Other intervention

    neuromuscular programm during 12 weeks (3 times a week, 10 minutes each time)

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: InterventionExperimental treatment 1 intervention
Group B: ControleNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

VO2 max, lactate

The study aims to examine the effects of a 12-week supplemental muscle program on cardiopulmonary exercise testing, focusing on key metrics such as maximum oxygen uptake (VO2max in mL/kg/min with capillary lactate measurement in mmol/L)

Time frame
Before the start of the 12-week muscular training program (pre-intervention) and immediately after the 12-week intervention (post-intervention).
2

Heart rate variability

The study aims to examine the effects of a 12-week supplemental muscle program on cardiopulmonary exercise testing, focusing on key metrics such as heart rate variability (HRV in ms).

Time frame
Before the start of the 12-week muscular training program (pre-intervention) and immediately after the 12-week intervention (post-intervention).
3

Body composition

The study aims to examine the effects of a 12-week supplemental muscle program on cardiopulmonary exercise testing, focusing on key metrics such as body composition (percentage of body fat, muscle mass in kg). Height will be measured in centimeters (cm) and weight in kilograms (kg) to calculate the Body Mass Index (BMI) in kg/m²

Time frame
Before the start of the 12-week muscular training program (pre-intervention) and immediately after the 12-week intervention (post-intervention).

Secondary outcomes

1

Hormonal changes: Cortisol

The study includes a secondary endpoint involving the measurement of cortisol levels (in μg/dL) before and after the muscular training program. These measurements offer valuable insights into the endocrine adaptations induced by the training regimen. By analyzing changes in cortisol levels, researchers can gain a deeper understanding of the hormonal milieu associated with muscle development, recovery, and overall physiological balance.

Time frame
Before the start of the 12-week muscular training program (pre-intervention) and immediately after the 12-week intervention (post-intervention).
2

Hormonal changes: Testosterone

The study includes a secondary endpoint involving the measurement of testosterone levels (in ng/dL) before and after the muscular training program. These measurements offer valuable insights into the endocrine adaptations induced by the training regimen. By analyzing changes in testosterone levels, researchers can gain a deeper understanding of the hormonal milieu associated with muscle development, recovery, and overall physiological balance.

Time frame
Before the start of the 12-week muscular training program (pre-intervention) and immediately after the 12-week intervention (post-intervention).

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: